We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties. You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies. In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Unveiling Synchrony (SYF) Q4 Outlook: Wall Street Estimates for Key Metrics
Read MoreHide Full Article
In its upcoming report, Synchrony (SYF - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $0.96 per share, reflecting a decline of 23.8% compared to the same period last year. Revenues are forecasted to be $4.45 billion, representing a year-over-year increase of 8.4%.
Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 2.3% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
That said, let's delve into the average estimates of some Synchrony metrics that Wall Street analysts commonly model and monitor.
The combined assessment of analysts suggests that 'Efficiency Ratio' will likely reach 33.6%. Compared to the current estimate, the company reported 37.2% in the same quarter of the previous year.
According to the collective judgment of analysts, 'Net interest margin' should come in at 15.1%. The estimate compares to the year-ago value of 15.6%.
The consensus among analysts is that 'Net charge-offs as of average loan receivables' will reach 5.5%. The estimate compares to the year-ago value of 3.5%.
The average prediction of analysts places 'Total interest-earning assets - Average Balance' at $116.40 billion. Compared to the present estimate, the company reported $104.53 billion in the same quarter last year.
Analysts expect 'Tier 1 Risk-based Capital Ratio' to come in at 12.9%. The estimate compares to the year-ago value of 13.6%.
Analysts predict that the 'Platform Analysis - Digital - Average loan receivables, including held for sale' will reach $27.76 billion. Compared to the present estimate, the company reported $23.93 billion in the same quarter last year.
Analysts' assessment points toward 'Platform Analysis - Digital - Purchase volume' reaching $15.36 billion. Compared to the present estimate, the company reported $14.79 billion in the same quarter last year.
The consensus estimate for 'Platform Analysis - Diversified & Value - Period-end loan receivables' stands at $20.08 billion. The estimate compares to the year-ago value of $18.62 billion.
Analysts forecast 'Platform Analysis - Diversified & Value - Average loan receivables, including held for sale' to reach $19.47 billion. The estimate is in contrast to the year-ago figure of $17.27 billion.
Based on the collective assessment of analysts, 'Platform Analysis - Health & Wellness - Purchase volume' should arrive at $4.01 billion. Compared to the present estimate, the company reported $3.51 billion in the same quarter last year.
The collective assessment of analysts points to an estimated 'Platform Analysis - Health & Wellness - Period-end loan receivables' of $14.81 billion. The estimate compares to the year-ago value of $12.18 billion.
It is projected by analysts that the 'Platform Analysis - Health & Wellness - Average loan receivables, including held for sale' will reach $14.18 billion. The estimate compares to the year-ago value of $11.85 billion.
Over the past month, Synchrony shares have recorded returns of -2.3% versus the Zacks S&P 500 composite's +0.6% change. Based on its Zacks Rank #3 (Hold), SYF will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Unveiling Synchrony (SYF) Q4 Outlook: Wall Street Estimates for Key Metrics
In its upcoming report, Synchrony (SYF - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $0.96 per share, reflecting a decline of 23.8% compared to the same period last year. Revenues are forecasted to be $4.45 billion, representing a year-over-year increase of 8.4%.
Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 2.3% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
That said, let's delve into the average estimates of some Synchrony metrics that Wall Street analysts commonly model and monitor.
The combined assessment of analysts suggests that 'Efficiency Ratio' will likely reach 33.6%. Compared to the current estimate, the company reported 37.2% in the same quarter of the previous year.
According to the collective judgment of analysts, 'Net interest margin' should come in at 15.1%. The estimate compares to the year-ago value of 15.6%.
The consensus among analysts is that 'Net charge-offs as of average loan receivables' will reach 5.5%. The estimate compares to the year-ago value of 3.5%.
The average prediction of analysts places 'Total interest-earning assets - Average Balance' at $116.40 billion. Compared to the present estimate, the company reported $104.53 billion in the same quarter last year.
Analysts expect 'Tier 1 Risk-based Capital Ratio' to come in at 12.9%. The estimate compares to the year-ago value of 13.6%.
Analysts predict that the 'Platform Analysis - Digital - Average loan receivables, including held for sale' will reach $27.76 billion. Compared to the present estimate, the company reported $23.93 billion in the same quarter last year.
Analysts' assessment points toward 'Platform Analysis - Digital - Purchase volume' reaching $15.36 billion. Compared to the present estimate, the company reported $14.79 billion in the same quarter last year.
The consensus estimate for 'Platform Analysis - Diversified & Value - Period-end loan receivables' stands at $20.08 billion. The estimate compares to the year-ago value of $18.62 billion.
Analysts forecast 'Platform Analysis - Diversified & Value - Average loan receivables, including held for sale' to reach $19.47 billion. The estimate is in contrast to the year-ago figure of $17.27 billion.
Based on the collective assessment of analysts, 'Platform Analysis - Health & Wellness - Purchase volume' should arrive at $4.01 billion. Compared to the present estimate, the company reported $3.51 billion in the same quarter last year.
The collective assessment of analysts points to an estimated 'Platform Analysis - Health & Wellness - Period-end loan receivables' of $14.81 billion. The estimate compares to the year-ago value of $12.18 billion.
It is projected by analysts that the 'Platform Analysis - Health & Wellness - Average loan receivables, including held for sale' will reach $14.18 billion. The estimate compares to the year-ago value of $11.85 billion.
View all Key Company Metrics for Synchrony here>>>
Over the past month, Synchrony shares have recorded returns of -2.3% versus the Zacks S&P 500 composite's +0.6% change. Based on its Zacks Rank #3 (Hold), SYF will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>